Objective Are first trimester serum pregnancy-associated plasma protein-A (PAPP-A), nuchal translucency (NT) and crown-rump length (CRL) prognostic factors for adverse pregnancy outcomes?
INTRODUCTION
Adverse pregnancy outcomes have a psychological impact for the family as well as an increased cost of healthcare. Methods of prediction would allow obstetricians to provide increased obstetric surveillance, focusing optimum management and possibly improving the outcome of the pregnancy.
Pregnancy-associated plasma protein A (PAPP-A) is a placental glycoprotein produced by syncytial trophoblast of the placenta, which cleaves insulin-like growth factor binding protein 4 (IGFBP4) and is a positive regulator of insulin-like growth factors (IGFs), 1 potentially influencing fetal growth
and wellbeing.
Studies have tested the hypothesis that low maternal serum levels of PAPP-A in the first trimester is a prognostic factor for adverse pregnancy outcomes associated with poor placental function. [2] [3] [4] [5] [6] International Guidelines on 'The Investigation and Management of the Small for Gestational Fetus' have recommended that pregnant women with a serum PAPP-A < 0.4MoM (5th centile) in the first trimester receive increased ultrasound surveillance for fetal growth disorders. 7 This recommendation was based on a previous systematic review by our group in 2008 assessing Down syndrome markers to predict pre-eclampsia (PE) and SGA. 8 This review included only 16 studies, did not assess all outcomes and did not distinguish between prognosis and prediction. However, contradictory results have been observed in publications, 6, 9 and few studies have investigated the association of first trimester fetal biometry [nuchal translucency (NT) and crown-rump length (CRL)] with adverse outcomes and their relationship with PAPP-A. 3, 10 Resolution of this is required, because genuine prognostic factors in this field have many potential uses. As outlined by the PROGRESS series, [11] [12] [13] [14] they may guide clinical decisions and monitoring strategies, inform the design and analysis of new trials and improve models for individualised risk prediction. Factors that add additional (independent) prognostic information are difficult to find but are needed to improve the discrimination performance of a 'prognostic model' 13 that produces absolute risk predictions for women based on a set of individual characteristics. 11 Our objective was to undertake a large cohort study to determine whether serum PAPP-A, NT and CRL in the first trimester are independent prognostic factors for the risk of subsequent adverse pregnancy outcomes.
METHODS

Data collection
In a retrospective cohort study, data were collected from patients booked from 1 August 2011 (commencement of electronic maternity record) to 31 March 2015 at the Birmingham Women's Foundation Trust (BWNFT); a secondary and tertiary care NHS hospital in West Midlands, UK. All pregnant women who accepted first trimester aneuploidy screening and delivered in BWNFT were included in the study. First trimester aneuploidy screening is offered to all pregnant women between 11 + 2 to 14 + 1 weeks of gestation (CRL measures from 45 to 84 mm) as part of the National Down's Syndrome Screening Programme. 15, 16 This involves measuring maternal serum levels of PAPP-A and free beta human chorionic gonadotrophin (fβHCG), along with the NT, and the pregnancy is dated on the basis of CRL. All first trimester scans and measurements performed at BWNFT are performed by accredited sonographers according to National NEQAS guidelines. 17 First day of the last menstrual period was obtained from the referring letter from the community midwife or hospital. This date was confirmed with the mother at the ultrasound visit, and additional information on the regularity and cycle duration was obtained. Analysis for PAPP-A was performed on the Auto-Delfia immunoassay platform (Perkin Elmer Ltd, Seer Green, UK). For the purpose of Down syndrome screening, PAPP-A values are converted to multiples of the median for gestation. In this study, to prevent any loss of data 18 and to remove the need for considering an absolute threshold, PAPP-A values were considered as a continuous variable using the absolute value (mU/L). To aid the presentation and interpretation of results, PAPP-A values were rescaled by dividing the values by 1000; therefore, the results relate to PAPP-A values in U/L. Multiple hospital-based, secure and confidential computerised databases were used to extract the information for the study, and governance from the hospital-based IT and Caldecott Guardian were prospectively obtained. Maternal and pregnancy outcome data were collected from K2 database, Neonatal data were collected from Badgernet database, and biochemistry data were collected from a biochemistry database. The collected data consisted of maternal characteristics and demographics; maternal medical, antepartum, peripartum and pregnancy outcome data along with first trimester serum PAPP-A levels, NT and CRL. Multiple gestations, pregnancies with donor eggs, missing outcome and known fetal aneuploidy were excluded. Cases of aneuploidy were cross referenced with the West Midlands Regional Genetics Laboratory database. 
Definitions of maternal and obstetric characteristics
Analysis of prognostic association with outcomes
Univariable logistic regression analysis was used to estimate the unadjusted odds ratio (OR) for each potential prognostic factor (PAPP-A/NT/CRL) separately. The OR indicates how much the odds of the outcome are increased for each one unit increase in the factor. Again, for each of the three factors separately, multivariable logistic regression analyses were fitted to examine the OR adjusted for the known (or likely) existing prognostic factors of maternal age (years), parity, BMI, smoking status, IVF, ethnicity, deprivation category and gestational diabetes. This provided the adjusted OR for a one unit increase in each factor, to reveal their independent prognostic value over and above other factors.
Then, for each outcome, the three factors were analysed in combination in one multivariable logistic regression model, whilst adjusting for the other factors detailed previously, to explore whether the prognostic value of each factor is the same after adjusting for the other two potential prognostic factors. The linearity assumption of all continuous variables was assumed for these multivariable models.
Therefore, finally, the fully adjusted models with all three potential factors in combination were fitted again; however, additionally, the linearity assumption of the prognostic effects for the three factors of interest was assessed, and alternative functional forms were considered if the assumption was violated. Else, a linear relationship was specified for all three prognostic factors of interest. The functional form was chosen using fractional polynomials, where all possible fractional polynomials up to the second degree were considered based on their statistical significance. 21 A linear relationship was specified for the other continuous covariates (maternal age and BMI). In all multivariable models described previously, no model selection process was used to determine which factors were included in each model, since all variables were pre-specified.
Handling of missing data
The percentages of missing values for each covariate and outcome were calculated. Missing data were imputed with multiple imputation with chained equations with 35 imputed datasets equal to the percentage of patients with missing data. 22 For non-normally distributed variables, predictive mean matching was used to impute the missing data. 23 The imputation model contained all complete outcomes and covariates that were included in the multivariable analyses. Rubin's rules were used to combine the parameter estimates and standard errors into a single inference. 24 A complete-case analysis was also conducted as a sensitivity analysis.
Estimates of prognostic effects are reported as OR with 95% confidence intervals (CI) and p-values. Analyses were performed using Stata version 14, 25 and all regression models were fitted using maximum likelihood estimation.
RESULTS
Between August 2011 and March 2015, first-trimester combined screening was performed in 12 837 pregnant women. Ten pregnancies conceived with donor eggs were excluded. Three pregnancies with an unclear pregnancy outcome showing NND post 28 days were excluded because this outcome would not be routinely recorded in the databases. After excluding 232 multiple pregnancies, the final study cohort was of 12 592 singleton pregnancies. As depicted in Table 1 , the mean maternal age and median BMI were 30.6 (SD 5.6) and 25.1 (IQR 22.4 to 28.8), respectively. The majority of the women were White British European (62.6%) followed by South-Asian (19.9%). Mean gestational age at first trimester ultrasound was 88.2 days (SD 4.3). About 2% (n = 250) of pregnancies were the result of assisted conception. Smoking status was known for all women, and 12.4% were ongoing smokers in the pregnancy, 84.3% nonsmokers and 3.3% had given up at the time of first trimester booking appointment. Nearly half (43.6%, n = 5495) patients lived in the most deprived areas (deprivation score ≥ 34.18) and 3.6% (n = 455) patients lived in the least deprived areas (deprivation score ≤ 8.49). Gender distribution was almost equal in the fetuses (48.6% male and 51.1% female).
Body mass index was missing in 4466 (35.5%) records, parity was missing in 567 (4.5%) and deprivation score was missing in 175 (1.4%) records. There were missing data for 152 (1.2%) fetal weight and four (0.03%) neonatal outcomes. Multiple imputation was performed for missing BMI (height, weight), parity and deprivation score values. Although some variables were normally distributed, predictive mean matching was used for all variables because imputation with chained regression analysis imputed unrealistic values for weight and height. Table 2 displays the number of events for each outcome for the cohort, and the prognostic association of PAPP-A, NT and CRL with these outcomes in the unadjusted analyses. Of 12 592 women, 852 had PTB (6.8%), 352 patients had PE (2.8%) and 1824 babies were SGA (14.5%). There were 73 pregnancies that ended in miscarriage (0.6%) and 37 stillbirths (0.3%). There were 38 NNDs (0.31%) of which 36 were early and thus giving a total of 73 perinatal deaths (0.6%).
Pregnancy-associated plasma protein-A results
In the unadjusted analysis (Table 2) , a one unit increase in the concentration of PAPP-A (U/L) was estimated to lower the odds of an SGA neonate by 13%, which was highly significant [OR 0.87 (95% CI 0.85, 0.90), p < 0.0001]. Similar conclusions can be drawn for the association between (Table S4) , perinatal death (Table S6 ) and NND (Table S7) remained non-significant in the multivariable analyses.
Nuchal translucency results
In the unadjusted analyses ( (Table S11 ). There was no significant relationship between NT and PTB, PE, stillbirth, perinatal or NND in the unadjusted or adjusted analyses (Tables S9, S10 , S12, S13, S14).
Crown-rump length results
For CRL in the unadjusted analysis, there was no significant association with any of the outcomes (Table 2 ). There was a borderline statistical significance for SGA that remained after adjustment [OR 0.99 (95% CI 0.99, 1.00, p = 0.057)] (Table 3) , but the magnitude of the OR was close to one. After adjustment for other known predictors and potential confounders, there was evidence of a strong association between CRL and stillbirth [OR 0.94 (95% CI 0.89, 0.99), p = 0.027], thus between 1% and 11% lower odds of stillbirth for a one unit increase in CRL. The adjusted analyses for PTB, PE, miscarriage, perinatal death and NND demonstrated no significant association with CRL (Tables S15-S21) .
Pregnancy-associated plasma protein-A, nuchal translucency and crown-rump length in combination
Assuming linear functions for all continuous variables, the three potential prognostic factors were then considered in combination with adjustment for confounders and known prognostic factors as discussed (Tables S22-28 For PTB (Table S23) (Table S24) .
There remained a statistically significantly increased odds of miscarriage as NT increases [OR 1.67 (95% CI 1.01, 2.76), Neonatal death includes babies that die between birth and 7 days after birth that are captured within the perinatal death category. SGA small for gestational age (birth weight < 10th customised centile). Odds ratios indicate the effect of one unit increase in the factor on the odds of the outcome. p = 0.047], and no evidence of associations between miscarriage and PAPP-A or CRL (Table S25 ). There was not any strong evidence (e.g. based on statistical significance at the 5% level) of any associations between stillbirth and any of PAPP-A, NT or CRL, unlike the individual models (Table S26 ). There was no evidence of associations between any of the three factors of interest and perinatal or NND (Tables S27-28) . After checking the linearity assumption of the three prognostic factors, all the previously identified prognostic associations remained the same. However, the log transformation was statistically the best fitting functional form of PAPP-A for SGA, and 1/ ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi PAPP À A p was statistically the best fitting functional form of PAPP-A for PTB. For PAPP-A for all other outcomes and for CRL and NT for all outcomes, the best fitting functional form was the linear function (see Tables S29-S31 ).
All the findings remained the same in the complete case analysis.
DISCUSSION Main findings
This large cohort study provides strong evidence that lower values of PAPP-A are associated with an increased odds of SGA, stillbirth, PE and PTB. As NT increases, there is evidence of a lower odds of SGA, but higher odds of miscarriage. As CRL decreases, there is evidence of higher odds of stillbirth. Neonatal and perinatal deaths were not associated with any of the prognostic factors measured in the first trimester. When considered in combination, there is a statistically significant association of PAPP-A, NT and CRL with SGA; PTB with PAPP-A, PE with PAPP-A and CRL, and miscarriage with NT. In the combined model, stillbirth is no longer associated with any of the factors.
Strengths and limitations
Our study has several strengths. This is a large cohort study looking at multiple pregnancy outcomes providing reproducible statistical results. The UK is a country where high quality and homogenous universal health care is provided to its residents free of charge and irrespective of socioeconomic and other statuses. This made our cohort a true representative of the general population avoiding bias due to skewed demographics. Certain factors that are known to affect pregnancy outcome, such as ethnicity, parity, maternal age and BMI, socio economic deprivation, smoking status and pre-pregnancy insulin-dependent diabetes mellitus, have been adjusted for in our analysis. We have made an effort to look for lesser researched possible associations, such as miscarriage and neonatal/perinatal death. Despite these strengths, our study is not without limitations. The data for potential confounding factors (existing prognostic factors) were limited to that which is routinely collected in our electronic maternity record as this was a retrospective study. Similarly, the outcomes are limited to those routinely recorded, and thus it was not possible to look at different thresholds that might confer a more severe outcome, for example, birth weight <5th or 3rd customised centile or severe PE. However, as our study was designed to investigate the independent prognostic ability of first trimester factors with adverse outcome, it can be argued that when a factor is prognostic, this relationship will be stronger for higher thresholds for the same outcome. Although the databases were not designed for this particular study, they are populated by qualified health professionals, and data were obtained from multiple sources to allow crossreferencing and checking of outcomes. The biochemistry data are part of the National Screening Programme and thus subject to the relevant quality assurance (UK National external quality assurance scheme (UKNEQAS), Edinburgh Royal Infirmary, UK and Downs syndrome screening quality assurance and support service (DQASS), University of Plymouth UK). Our sample was determined by the number of patients available with an electronic record and outcome data and thus not determined by a sample size calculation. Most CIs were quite narrow, but we recognise that nonsignificant findings do not necessarily mean that no prognostic association exists and may simply reflect a low power to detect genuine associations. Nevertheless, many CIs were relatively narrow, and the prognostic associations identified were often strongly statistically significant. The clinical utilisation of CRL as an individual prognostic factor (i.e. outside of a model using it as a continuous factor) is less clear as standard care in the UK is for a single first trimester ultrasound to incorporate dating (using CRL) and NT for aneuploidy risk. Previous studies have assessed the prognostic value of difference in expected to observed CRL based on the last menstrual period, 10 observed versus expected change in CRL in the first trimester 27 and CRL as a continuous factor in multivariable analysis. 28 The use of CRL to date a pregnancy assumes that there is no growth variation within the first trimester nor association with factors such as fetal sex, maternal age or ethnicity.
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A study from the Netherlands demonstrated that CRL in the first trimester was associated with an increased risk of adverse birth outcomes and postnatal growth acceleration. 28 Standard care in the UK is only to offer one first trimester ultrasound; thus, it is not possible to assess CRL change, and the use of the CRL to date the pregnancy does not allow the assessment of observed to expected CRL. We thus wished to assess whether CRL, measured between the 11 + 2-14 + 1 week window, assessed as a continuous variable had a relationship with adverse pregnancy outcome, i.e. in particular assessing extremes of the continuum.
Interpretation
The aim was to provide more evidence toward establishing if the prognostic factors of interest can be used to further inform the management of potential adverse outcomes, for example by increased surveillance for pregnant women at greater risk. The results showed evidence of associations between the potential prognostic factors and several outcomes, and the associations remained largely the same when the factors were considered in combination. Future work is now important to establish whether the findings from all prognostic factor studies are consistent by synthesising the evidence. The evidence from this study supports the need for women with pregnancies with a low PAPP-A and increased NT being under Consultant-led care and the recommendation within the RCOG guidelines 7 for increased surveillance for SGA in pregnancies with a low PAPP-A and supports this being extended to pregnancies in the first trimester with an increased NT. At present, until a model is developed that can incorporate these factors as continuous variables, it would be appropriate to use accepted thresholds of <5th centile for PAPP-A and >99th centile for NT. Due to the association with low PAPP-A and PTB and PE, these pregnancies should be assessed comprehensively for other risk factors for PTB and consideration given to the commencement of aspirin prior to 16 weeks. Independent prognostic factors have a broad array of potential uses in both clinical practice and health research. 12 For instance, they help to define disease at diagnosis; they may be modifiable in order for interventions to improve outcomes; they aid the design and analysis of trials; they are confounders to consider in observational studies and unbalanced trials; and they are the building blocks of prognostic models. 12 Prognostic factor research is therefore important to discover and evaluate such factors. We emphasise that our multivariable models were fitted to examine if there is evidence of an independent association between the potential prognostic factors of interest and the maternal and fetal outcomes after adjustment for known prognostic factors. Our objective was to assess the prognostic factors themselves and not on an overall prognostic model for individual risk prediction. This is especially important because there was no external data to validate such a model. 13 Future work could use new datasets to develop individual risk prediction models in order to tailor treatment choices to the individual and to look at different thresholds for the outcomes, for example, severe PE. Such models should build on the findings of this study, in terms of the prognostic factors that were identified as important.
CONCLUSION
When three first trimester potential prognostic factors are considered in combination, there remains strong evidence of associations between: a) PAPP-A, NT, CRL and SGA, b) PAPP-A only with PTB, c) PAPP-A and CRL for PE, d) NT and miscarriage. Further work is required to assess the predictive ability of these factors in prediction models for adverse pregnancy outcome.
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WHAT'S ALREADY KNOWN ABOUT THIS TOPIC?
• Low levels of PAPP-A are associated with small for gestational age and PE.
WHAT DOES THIS STUDY ADDS?
• NT, CRL and PAPP-A are independent prognostic markers for adverse pregnancy outcome. Further work is required to assess the predictive ability of these factors in prediction models.
